Ylenia Della Rocca | Medicine and Health Sciences | Research Excellence Award

Published on by Research Awards

Prof. Ylenia Della Rocca | Medicine and Health Sciences | Research Excellence Award 

Link University | Italy

Ylenia Della Rocca is an Associate Professor of Histology and Embryology and Physiology whose research profile is internationally recognized in the fields of stem cell biology, regenerative medicine, and advanced in vitro modeling for precision medicine. Her scientific activity is strongly interdisciplinary, integrating histology, embryology, molecular biology, biomaterials, and translational medicine, with a particular focus on induced pluripotent stem cells (iPSCs), extracellular vesicles, and 3D culture systems. Her core research line centers on the reprogramming of autologous human gingival mesenchymal stem cells into iPSCs and their differentiation toward functional cell types, especially cardiomyocytes and neural lineages. This work has led to innovative strategies for cardiac regeneration and personalized regenerative therapies, culminating in a patented non-integrative reprogramming and cardiomyogenic differentiation process. Through advanced molecular and morphological analyses, her studies elucidate the signaling pathways governing cell fate, inflammation, hypoxia response, and extracellular matrix remodeling. A distinctive element of her research is the development and application of organ-on-a-chip and tissue-on-a-chip platforms, including bone-on-a-chip and cardiac models, to study disease mechanisms, environmental pollutant toxicity, and therapeutic responses. Within national and international projects, she has contributed to the creation of physiologically relevant in vitro systems that reduce reliance on animal models while increasing translational relevance. Her work on environmental pollutants, such as bisphenol A and pesticides, has clarified their impact on inflammatory, apoptotic, and epigenetic pathways in stem cells and endothelial models.

View Orcid Profile

Featured Publications

Zbigniew Rybak | Health Professions | Research Excellence Award

Published on by Research Awards

Prof. Zbigniew Rybak | Health Professions | Research Excellence Award

Wroclaw Medical University | Poland

Prof. Zbigniew Rybak, MD, Ph.D. is a distinguished surgeon, academic, and innovator whose career spans five decades of clinical excellence, research leadership, and medical education. He has been continuously affiliated with Wrocław Medical University from 1975 to 2025, where he has played a pivotal role in advancing experimental surgery, vascular surgery, and biomaterials research. From 2010 to 2022, he served as Head of the Department of Experimental Surgery and Biomaterials Research, leading interdisciplinary research that bridged surgical practice with biomedical engineering and translational medicine. His later appointment at the Pre-Clinical Research Centre (2022–2025) further strengthened preclinical innovation and surgical modeling. Prof. Rybak’s international experience includes clinical and research work at Rikshospitalet, The National Hospital of Norway (1979–1981), and collaboration with the Department for Cardiovascular, General and Transplantation Surgery at Oslo Medical University, significantly enriching his global surgical perspective. Prof. Rybak is a prolific medical innovator and holds five patents addressing critical needs in surgery and biomedical technology, including devices for anorectal disease diagnosis and treatment, biomedical glue, pharmaceutical carriers, nanochloroapatite preparation processes, and a medical bed design. These inventions reflect his commitment to translating research into practical, patient-centered solutions. His research interests focus on vascular surgery, chronic wound management, biomaterials, minimally invasive and endovascular therapies, and the development of hybrid surgical techniques. A recognized leader in medical education, Prof. Rybak has led international surgical training courses across Europe, Asia, and the Americas. He has trained approximately 250 physicians in laser treatment of venous insufficiency, over 1,000 physicians in sclerotherapy since 2006, and 80 physicians in steam-based venous treatment techniques.

Citation Metrics (Scopus)

3000
2000
1000
  500
  400
  300
  200
  100
    50
    30
    10
      0

Citations
2502

Documents
92

h-index
19

Citations

h-index

i10-index

View Scopus Profile

Featured Publications

Yves Julien Mbama Biloa | Medicine and Health Sciences | Young Scientist Award

Published on by Research Awards

Mr. Yves Julien Mbama Biloa | Medicine and Health Sciences | Young Scientist Award 

Jean Monnet University | France

Mr. Yves Julien MBAMA BILOA is a dedicated emerging public health scholar whose research, teaching, and professional work converge around preventive health, clinical innovation, and population well-being. Born on May 16, 1996, in Cameroon, he is currently completing his Ph.D. in Public Health at Jean Monnet University of Saint-Étienne, France, where he will defend his doctoral thesis on December 18, 2025. His doctoral research—focused on developing a preventive clinical practice framework during the transition to retirement using the Delphi consensus method—positions him at the forefront of preventive healthcare innovation for aging populations. With a strong academic foundation in human biology, animal physiology, and epidemiology, he holds a Master’s degree in Biology and Physiology of Animal Organisms (2021) and a Bachelor’s degree in Human Biology and Health, both from the University of Douala, Cameroon. His expertise extends across qualitative and quantitative research methods, statistics, health promotion, and digital health applications. Yves has developed a robust professional background that includes university-level teaching, research contributions, and entrepreneurial experience. As a Public Health Teacher at Université Claude Bernard Lyon 1 and IRFSS-FI Rhône Alpes, he has delivered courses on social inequalities in health, nursing practices, and international mobility, shaping the perspectives of future healthcare professionals. His entrepreneurial initiative as the Founder of the Center for Statistical Processing and Analysis in Douala demonstrates his leadership in offering methodological support, statistical consulting, and academic mentorship to students and researchers. His skill set spans statistical analysis, epidemiological assessment, scientific writing, and the application of artificial intelligence in health. His publication record reflects growing expertise in preventive healthcare, retirement-transition health strategies, and emerging health challenges. He has authored and co-authored peer-reviewed articles in reputable journals such as Public Health, Journal of Public Health (Berlin), BMC Infectious Diseases, and Journal of Health, Population and Nutrition. His works include a Delphi-based preventive clinical practice framework, a scoping review on periodic health examinations during retirement transition, a mixed-methods protocol for evaluating Long Covid interventions (SPACO+), and studies on cardioprotective effects of methotrexate and metabolic syndrome among students. His research aims to strengthen health systems, empower healthcare decision-making, and enhance preventive care models, especially within the contexts of aging, chronic diseases, and digital health transformation. After completing his Ph.D., he intends to advance his expertise in health prevention, mental health, digital health, and health system improvement, contributing impactful and evidence-based insights to global public health

Profiles: Scopus | Orcid

Featured Publications

Development of a preventive clinical practice framework for transition to retirement

Mbama Biloa, Y. J., Rozand, V., Oriol, M., Guindo, Y., Botelho-Nevers, E., & Bongue, B. (2025). Development of a preventive clinical practice framework for transition to retirement: A Delphi consensus of French physicians. Public Health, 249, 106003.

SPACO+: A mixed methods protocol for assessing the effectiveness of an educative intervention in patients with Long Covid

Kamdem, O. L., Dupre, C., Heugno, V., Baudot, A., Essangui, E., Blanquet, M., Guercon, N., Fanget, M., Bayet, S., Vericel, M. P., et al., & Mbama Biloa, Y. J. (2025). SPACO+: A mixed methods protocol to assessing the effectiveness of an educative intervention in patients with Long Covid. BMC Infectious Diseases, 25, 623.

Periodic health examination during transition to retirement: A scoping review

Mbama Biloa, Y. J., Rozand, V., Kamdem, L., Regnier-Denois, V., Botelho-Nevers, E., & Bongue, B. (2025). Periodic health examination during transition to retirement: A scoping review. Journal of Public Health (Berlin).

Unveiling the hidden shield: Methotrexate as a cardio-protector in psoriasis

Mai, S., Mbama, Y., Gouttefarde, P., Franck, T., Cizeron, G., Oriol, M., Maccari, F., Trombert, B., Bongué, B., & Perrot, J.-L. (2024). Unveiling the hidden shield: Methotrexate emerges as a cardio-protector in psoriasis—Insights from a scoping review [Preprint]. HAL Archive.

Prevalence of metabolic syndrome and components in rural, semi-urban, and urban areas in Cameroon

Bilog, N. C., Mekoulou Ndongo, J., Bika Lele, E. C., Guessogo, W. R., Assomo-Ndemba, P. B., Ahmadou, … Mbama Biloa, Y. J., … Temfemo, A. (2023). Prevalence of metabolic syndrome and components in rural, semi-urban and urban areas in the littoral region in Cameroon: Impact of physical activity. Journal of Health, Population and Nutrition, 42, 95.

Javad Amini Mahabadi | Health Sciences | Editorial Board Member

Published on by Research Awards

Dr. Javad Amini Mahabadi | Health Sciences | Editorial Board Member

Anatomical and Gametogenesis Research Center | Iran

Dr. Javad Amini Mahabadi is an accomplished Iranian researcher in reproductive biology, stem cell science, and assisted reproductive technologies, affiliated with the Gametogenesis Sciences Research Center and the Anatomical Sciences Research Center at Kashan University of Medical Sciences, as well as the Sarem Gynecology, Obstetrics and Infertility Research Center and the Sarem Cell Research Center in Tehran. Born on 22 March 1985 in Ardestan, Isfahan, he holds a Ph.D. in Reproductive Biology from Kashan University of Medical Sciences, an M.Sc. in Animal Physiology from the University of Zanjan, and a B.Sc. in Animal Science from Razi University. His research interests span reproductive biology, IVF and ICSI, stem cells, medical genetics, histopathology, physiology, and animal science. Dr. Amini Mahabadi has an impressive scientific footprint with h-index 12 in Google Scholar and 9 in Scopus, reflecting influential contributions in male fertility, germ cell differentiation, embryonic development, nanofiber-based stem cell engineering, and the protective effects of natural compounds on reproductive tissues. He has authored and co-authored more than 20 international journal papers in highly regarded outlets such as Andrologia, Journal of Cellular Biochemistry, Cytotherapy, Journal of Cellular Physiology, Theriogenology, and Gene, as well as several internal journal publications. His scholarly works include pioneering studies on the differentiation of induced pluripotent stem cells into male and female germ cell lineages, microRNA roles in stem cell biology, reproductive toxicity, and therapeutic approaches using natural extracts and biomaterials. With extensive experience in laboratory animal handling, histological and molecular techniques, MEF and iPSC culture, IVF/ICSI procedures, and embryology, he is also well-versed in advanced assays including flow cytometry, real-time PCR, Western blotting, immunocytochemistry, and micromanipulation. Dr. Amini Mahabadi has supervised numerous research projects and actively served as a referee for journals such as the Iranian Journal of Basic Medical Sciences and Pharmaceutical Biology. He has taught at university level, delivered workshops on stem cell culture, sperm analysis, scientific writing, and research methodology, and contributed significantly to the student research committee at KAUMS. His professional training includes specialized courses in stem cell culture at Bonyakhteh Center, IVF and ICSI at Kashan Beheshti Hospital, and ART techniques at Sarem Women’s Hospital. Supported by a strong network of academic referees, Dr. Amini Mahabadi continues to advance reproductive science through rigorous research, clinical collaboration, and scientific mentorship.

Profile: Scopus | Orcid

Featured Publications

Amini Mahabadi, J., Enderami, S. E., Nikzad, H., Hassani Bafrani, H., & Sanchez, R. (2024).
The use of machine learning for human sperm and oocyte selection and success rate in IVF methods. Andrologia. https://doi.org/10.1155/and/8165541

Giti, S., Amini Mahabadi, J., & Nateghi, M. R. (2022).
A case report of papyrus fetus. Sarem Journal of Medical Research, 7(1), 25. https://doi.org/10.61186/sjrm.7.1.25

Nateghi, M. R., & Amini Mahabadi, J. (2022).
Investigating the expression of mesenchymal stem cell markers in human bone marrow stem cells. Sarem Journal of Medical Research, 7(3), 165. https://doi.org/10.61186/sjrm.7.3.165

Abazari, M. F., Soleimanifar, F., Amini Faskhodi, M., Mansour, R. N., Amini Mahabadi, J., Sadeghi, S., Hassannia, H., Saburi, E., Enderami, S. E., Khani, M. M., et al. (2020).
Improved osteogenic differentiation of human induced pluripotent stem cells cultured on polyvinylidene fluoride/collagen/platelet-rich plasma composite nanofibers. Journal of Cellular Physiology. https://doi.org/10.1002/jcp.29029

Shafiei, G., Almasi, M., Nikzad, H., Miyan, J., Mahabadi, J. A., & Moshkdanian, G. (2020).
L-carnitine reduces the adverse effects of ROS and up-regulates the expression of implantation-related genes in in vitro developed mouse embryos. Theriogenology. https://doi.org/10.1016/j.theriogenology.2020.01.008

Tahmasebi, A., Enderami, S. E., Saburi, E., Islami, M., Yaslianifard, S., Mahabadi, J. A., Ardeshirylajimi, A., Soleimanifar, F., & Moghadam, A. S. (2020).
Micro-RNA-incorporated electrospun nanofibers improve osteogenic differentiation of human-induced pluripotent stem cells. Journal of Biomedical Materials Research: Part A. https://doi.org/10.1002/jbm.a.36824

Amini Mahabadi, J., Karimian, M., Aghighi, F., Enderami, S. E., Seyyed Hosseini, E., Talaei, S. A., Gheibi Hayat, S. M., & Nikzad, H. (2020).
Retinoic acid and 17β-estradiol improve male germ cell differentiation from mouse-induced pluripotent stem cells. Andrologia. https://doi.org/10.1111/and.13466

Aliyar Mirzapour | Medicine and Health Sciences | Editorial Board Member

Published on by Research Awards

Assist Prof Dr. Aliyar Mirzapour | Medicine and Health Sciences | Editorial Board Member 

Departement of parasitology and Mycology, School of Medicine Islamic Azad University Mashhad Branch | Iran

Dr. Aliyar Mirzapour is an accomplished Iranian parasitologist and medical researcher affiliated with the Department of Parasitology and Mycology, School of Medicine, Islamic Azad University, Mashhad Branch. His scholarly contributions span a wide range of parasitic diseases, with a strong emphasis on systematic reviews, meta-analyses, molecular diagnostics, zoonotic parasites, and epidemiological patterns of infections affecting both humans and animals. Over the years, Mirzapour has contributed significantly to understanding soil-transmitted helminths, protozoan infections, zoonotic risks, and vector-borne diseases prevalent in Iran and across the globe. His work has been widely referenced, demonstrating growing recognition within the parasitology and public health communities. One of his most influential collaborations includes research on Toxoplasma gondii and Toxocara spp., where he co-authored systematic reviews and meta-analyses exploring global and regional prevalence, geo-climatic factors influencing infection, and the potential association of parasitic exposure with neurological disorders such as schizophrenia. These studies have provided valuable insights into risk factors, transmission dynamics, and the public health burden of toxoplasmosis and toxocariasis, helping policymakers prioritize preventive strategies. Mirzapour has also contributed to investigations on soil contamination in public areas, documenting the presence of Toxocara eggs and Toxoplasma oocysts, which represent critical sources of human infection. His work in this area has strengthened awareness about environmental hygiene and zoonotic disease management. In addition to epidemiological research, Mirzapour has conducted laboratory-based and molecular studies focused on Leishmania species, Echinococcus granulosus, nontuberculous mycobacteria, and helminths. Notably, he has published reports on cutaneously infected patients with mixed Leishmania species, explored intra-species diversity using ITS1-rDNA analysis, and participated in designing multi-epitope recombinant antigens aimed at improving diagnostic accuracy for cystic echinococcosis. His work on immunomodulation, particularly studies involving naltrexone and naloxone as vaccine adjuvants against Fasciola hepatica, reflects his interest in advancing vaccine formulations and host-immune response research. Mirzapour’s contributions further include parasitological surveys in wildlife and zoo animals, identification of rare parasites such as Bivitellobilharzia nairi in elephants, and diagnostic studies using high-performance liquid chromatography for Mycobacterium species differentiation. His broad expertise, spanning field sampling, molecular techniques, immunology, and evidence synthesis, highlights his dedication to improving parasitic disease control and public health outcomes. Through consistent publication and collaboration, Aliyar Mirzapour has established himself as a valuable researcher in contemporary parasitology.

Profile: Google Scholar

Featured Publications

Behravan, M., Panahi, A. H., Naghizadeh, A., Ziaee, M., Mahdavi, R., … (2018). Facile green synthesis of silver nanoparticles using Berberis vulgaris leaf and root aqueous extract and its antibacterial activity. International Journal of Biological Macromolecules, 781.

Maleki, B., Ahmadi, N., Olfatifar, M., Gorgipour, M., Taghipour, A., Abdoli, A., … (2021). Toxoplasma oocysts in the soil of public places worldwide: A systematic review and meta-analysis. Transactions of the Royal Society of Tropical Medicine and Hygiene, 115(5), 53.

Maleki, B., Khorshidi, A., Gorgipour, M., Mirzapour, A., … (2017). Prevalence of Toxocara spp. eggs in soil of public areas in Iran: A systematic review and meta-analysis. Alexandria Journal of Medicine, 52.

Rostami, A., Riahi, S. M., Omrani, V. F., Wang, T., … (2020). Global prevalence estimates of Toxascaris leonina infection in dogs and cats. Pathogens, 9(6), 503.

Nourollahpour Shiadeh, M., Esfandyari, S., Ashrafmansouri, M., … (2020). The prevalence of latent and acute toxoplasmosis in HIV-infected pregnant women: A systematic review and meta-analysis. Microbial Pathogenesis, 45(10), 149.

Rostami, A., Riahi, S. M., Esfandyari, S., Habibpour, H., … (2021). Geo-climatic factors and prevalence of chronic toxoplasmosis in pregnant women: A meta-analysis and meta-regression. Environmental Pollution, 288.

Taghipour, A., Habibpour, H., & Mirzapour, A. (2021). Toxocara infection/exposure and the risk of schizophrenia: A systematic review and meta-analysis. Transactions of the Royal Society of Tropical Medicine & Hygiene, 115(3), 18.

Mirzapour, A., Kiani, H., Mobedi, I., Spotin, A., Tabaei, S. J. S., & Rahimi, M. (2018). Frequency of intestinal parasites among zoo animals by morphometric criteria and first report of the Bivitellobilharzia nairi from elephant (Elephas maximus maximus) in Iran. Iranian Journal of Parasitology, 13(4), 611.

Michal Galek-Aldridge | Health Sciences | Best Scholar Award

Published on by Research Awards

Mr. Michal Galek-Aldridge | Health Sciences | Best Scholar Award

University Medical Center Utrecht | Netherland

Michał Gałek-Aldridge is a multilingual medical researcher and physician with a strong interdisciplinary background bridging molecular science, engineering, and regenerative medicine. Born on September 18, 1993, in Tucson, Arizona, he holds Polish nationality and is fluent in English, Dutch, Polish, and Russian, with advanced proficiency in French and beginner-level Portuguese. Michał’s academic journey spans multiple international institutions, including The British School of Warsaw, the Anglo-American School in Moscow, and the International School of Amsterdam, culminating in an International Baccalaureate (IB) bilingual diploma in 2011. He pursued a Bachelor of Science in Molecular Science and Technology at Delft University of Technology and Leiden University, completing his thesis on “The loading of chemotherapeutics in polymersome carriers” at the Reactor Institute Delft. During this period, Michał received an Erasmus Mundus scholarship to study at Chalmers University in Sweden, where he expanded his expertise in nuclear chemistry, project management, waste management, and ecology. Driven by a passion for medicine, he subsequently earned both a Bachelor and Master of Science in Medicine at the University of Amsterdam, with clinical experience in orthopedic surgery at the UMC Amsterdam. Since 2021, Michał has been a PhD candidate at the University Medical Center Utrecht, focusing on the translation of regenerative surgical shoulder implants into clinical practice. His research integrates advanced therapies, 3D-printed medical devices, and regenerative medicine, while also addressing regulatory compliance, intellectual property assessment, and GMP evaluation for ATMP production. He actively supervises students at the 3D Lab, contributing to both academic and translational research. His work is supported by prominent supervisors including Prof. Michel van den Bekerom, Dr. Arthur van Noort, Dr. Bart van der Wal, and Prof. Jos Malda. Michał has contributed extensively to the scientific literature, publishing as first author on innovative orthopedic treatments and as co-author in high-impact journals, including The Lancet Respiratory Medicine, Journal of Shoulder and Elbow Surgery, and JSES Reviews, Reports & Techniques. His research has spanned topics from patient-specific bone regenerative implants and congenital hip dislocation management to COVID-19 respiratory subphenotypes and ventilation strategies. Michał’s professional development is complemented by diverse certifications and conferences, including Medical Device Regulation (EU MDR 2018), ISO 13485, 3D printing in hospitals, and arthroscopy and arthroplasty courses. Outside of his professional endeavors, he maintains an active lifestyle through kickboxing, Muay Thai, skiing, kite surfing, and cooking. His combination of scientific rigor, clinical expertise, and entrepreneurial initiative positions him as a rising leader in regenerative medicine and medical innovation.

Profile: Scopus

Featured Publications

van Spanning, S. H., van Iersel, T. P., Verweij, L. P. E., van Noort, A., Floor, S., Galek-Aldridge, M., van den Borne, M. P. J., Kleinlugtenbelt, Y. V., van den Bekerom, M. P. J., & van Deurzen, D. F. P. (2025). Lower education level is associated with failure to return to sport whereas bony Bankart lesions predict successful return to preinjury sport level after open Latarjet procedure. Arthroscopy: The Journal of Arthroscopic & Related Surgery. Advance online publication.

 

Jitendra Patil | Health Sciences | Best Researcher Award

Published on by Research Awards

Mr. Jitendra Patil | Health Sciences | Best Researcher Award

Mr. Jitendra Patil | Sankalchand Patel University Visnagar,Badoda | India

Mr. Jitendra Hilal Patil, Lecturer at H.R. Patel Institute of Pharmaceutical Education and Research, Shirpur, is a PCI-registered academic with a strong background in pharmaceutical sciences and nanotechnology. He holds an M.Pharm in Quality Assurance and is pursuing his Ph.D. at Sankalchand Patel University, Visnagar. His research focuses on developing pH-responsive nanocarrier drug delivery systems for targeted cancer therapy, with publications in Scopus-indexed journals and one patent under process. With a citation index of 29, his innovative work contributes significantly to advancing precision medicine while minimizing systemic toxicity in anticancer treatments.

Author Profile 

Scopus

Education

From the very beginning of his educational journey, Mr. Jitendra Hilal Patil demonstrated a keen interest in pharmaceutical sciences and biomedical research. His strong academic foundation was built through consistent excellence across secondary and higher secondary education, which he pursued with dedication and discipline. His pursuit of a Bachelor’s and Master’s degree in Pharmacy further sharpened his knowledge in drug formulation, quality assurance, and advanced pharmaceutical principles. These formative academic years not only shaped his scientific mindset but also ignited his passion for research in nanotechnology and innovative drug delivery systems. His pursuit of a Ph.D. reflects his commitment to expanding the boundaries of knowledge and contributing to global healthcare challenges.

Experience

Mr. Patil serves as a Lecturer at H.R. Patel Institute of Pharmaceutical Education and Research, Shirpur, where he plays a pivotal role in nurturing future pharmacists and researchers. His teaching approach integrates theory with practical insights, encouraging students to think critically about real-world healthcare challenges. Alongside his teaching responsibilities, he actively engages in research, ensuring his academic contributions are aligned with the latest developments in pharmaceutical innovation. His ability to balance teaching, research, and mentoring highlights his versatility as both an educator and a researcher. He also ensures his students are exposed to cutting-edge topics such as nanotechnology, targeted therapies, and drug delivery systems, preparing them to excel in the evolving landscape of pharmaceutical sciences.

Research Focus

The hallmark of Mr. Patil’s academic journey lies in his research on pH-responsive nanocarrier drug delivery systems designed for targeted cancer treatment. Recognizing the limitations of conventional chemotherapy—such as poor survival rates, systemic toxicity, and severe side effects—he focused on developing titanium-based metal-organic frameworks (Ti-MOFs) as nanocarriers for the anticancer drug axitinib (AXT).

Through advanced hydrothermal synthesis and characterization techniques, he successfully developed stable, porous nanostructures that exhibit excellent pH-responsive behavior. His in vitro studies revealed that these carriers released minimal drug amounts in neutral pH, simulating healthy tissues, but significantly increased release in acidic environments mimicking cancer cells. This innovation represents a major step toward precision medicine, offering the potential to reduce toxicity and enhance therapeutic efficacy. His work exemplifies how nanotechnology can transform oncology treatments, opening doors to more effective and patient-friendly therapies.

Awards and Recognition

Mr. Patil’s research has garnered recognition through Scopus-indexed publications, citations, and a patent under process, highlighting the originality and applicability of his work. With a citation index of 29, his publications demonstrate a meaningful academic impact and a growing influence in the pharmaceutical research community. He is also a registered member of the Pharmacy Council of India (PCI), further strengthening his professional credibility. While he has not yet accumulated multiple industry consultancy projects or editorial appointments, his promising work and contributions reflect the qualities of a rising researcher who is set to achieve even greater recognition at both national and international levels.

Impact and Influence

The potential impact of Mr. Patil’s research extends beyond academia, offering transformative possibilities in cancer treatment. By addressing the challenges of drug toxicity and inefficient targeting, his nanocarrier-based system has the potential to improve the quality of life for patients undergoing therapy. Moreover, his contributions set a strong foundation for future collaborations in nanomedicine, oncology research, and pharmaceutical technology. His influence also extends to his students, who benefit from his mentorship, guidance, and emphasis on research-driven learning. By bridging the gap between classroom knowledge and practical innovation, he inspires a new generation of pharmaceutical professionals to pursue impactful research that addresses pressing healthcare challenges.

Publications

Nonlocal thermoelastic diffusion analysis in a semi-infinite body subjected to thermal loading with memory effects.

Author: Jitendra Patil, Chandrakant Jadhav, Nitin Chandel & Vinod Varghese
Journal: Archive of Applied Mechanics
Year: 2025

Development and Characterization of AXT@Metal-Organic Framework: A Biocompatible, pH-Responsive Nanocarrier for Targeted Axitinib Delivery in MCF-7 Cancer Cells.

Author: Jayvadan K. Patel, Ujashkumar A. Shah, Pravin O. Patil, Jitendra H. Patil
Journal: Annales Pharmaceutiques Françaises
Year: 2025

Conclusion

Mr. Jitendra Hilal Patil exemplifies the qualities of a dedicated educator, an emerging researcher, and an innovator in pharmaceutical sciences. His academic journey, professional commitments, and research on pH-responsive nanocarriers reflect not only his scientific expertise but also his vision for improving global healthcare outcomes. With a growing body of impactful publications, a patent under process, and recognition as a promising voice in nanotechnology and drug delivery research, he continues to inspire both peers and students alike. Looking forward, his unwavering dedication positions him to make enduring contributions that bridge cutting-edge research with tangible benefits for society, leaving a meaningful legacy in academia and beyond.

Cheng Ni | Health Sciences | Best Researcher Award | 13442

Published on by Research Awards

Prof. Cheng Ni | Health Sciences | Best Researcher Award

Prof. Cheng Ni, Cancer Hospital, Chinese Academy of Medical Sciences, China

Prof. Cheng Ni, M.D., Ph.D. is a Professor and Consultant Anesthesiologist at the Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, where he also serves as Associate Chief of the Department of Anesthesiology. With extensive clinical and academic experience in thoracic anesthesiology, perioperative neuroprotection, and cancer pain management, Prof. Ni has held key roles at leading institutions including Peking University and Harvard University. His research focuses on perioperative neurocognitive disorders, tumor immunology, and the application of AI in anesthesiology. He has published over 50 SCI-indexed articles and holds 11 authorized patents.

Profile

Scopus

🎓 Early Academic Pursuits

Prof. Cheng Ni’s academic journey is a testament to dedication and intellectual rigor. He began his medical education at Capital Medical University, earning his M.D. in 2003 and M.S. in 2005, laying a solid foundation in medical sciences. His passion for deeper understanding and specialization led him to pursue a Ph.D. at Peking University, one of China’s most prestigious institutions, which he completed in 2012. This advanced academic training equipped him with a rich knowledge base in anesthesiology and related biomedical sciences, paving the way for a distinguished career in clinical practice, teaching, and research.

🩺 Professional Endeavors

Prof. Ni’s professional career reflects a steady and impactful rise through China’s top-tier medical institutions. He began as a Resident at Peking University Third Hospital (2005–2008) and subsequently served as an Attending Anesthesiologist (2008–2015). During this period, he gained hands-on clinical experience and honed his leadership abilities.

In 2013–2014, he expanded his global perspective as a Postdoctoral Research Fellow at Harvard University, engaging with cutting-edge international research. Upon his return, he held several key administrative and academic roles at Peking University, including Chief Secretary of the Faculty of Anesthesiology, and Associate Consultant and Associate Professor.

In 2020, Prof. Ni joined the Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, a top national institution, as a Consultant and Associate Professor. His expertise quickly earned him leadership roles as Associate Chief of the Department of Anesthesiology, and by 2021, he was promoted to Professor and Consultant. He also became a Ph.D. Supervisor in 2023, mentoring the next generation of clinical researchers and specialists.

🔬 Contributions and Research Focus

Prof. Ni’s research contributions span multiple high-impact areas in modern anesthesiology and cancer care. His primary interests include:

  • Perioperative neurocognitive disorders 🧠

  • Thoracic anesthesiology and neuroprotection 💨🛡️

  • Cancer pain management 🧬

  • Genetics and tumor immunology 🧫

  • AI in anesthesiology research 🤖🩺

He has authored over 50 peer-reviewed articles in leading SCI-indexed journals, including Aging Cell, CNS Neuroscience & Therapeutics, Life Sciences, and Anesthesia & Analgesia. His recent publications explore the neuroinflammatory response during surgery, the effects of anesthesia on brain aging, and the integration of hybrid learning models for brain cell identification—blending medical science with artificial intelligence.

In addition to journal publications, Prof. Ni has contributed to 12 academic monographs and holds 11 authorized patents, underscoring his commitment to translational research and innovation.

🏅 Accolades and Recognition

Prof. Cheng Ni is widely respected in China’s medical and academic communities. His achievements have been recognized through his appointment to senior roles such as:

  • Chief Secretary of Anesthesiology Faculty, Peking University Health Science Center

  • Associate Chief of the Department of Anesthesiology at China’s National Cancer Center

  • Ph.D. Supervisor, guiding graduate-level research and fostering academic excellence

These appointments are not only acknowledgments of his skill and dedication but also affirmations of his influence in shaping anesthesiology and cancer care practices in China.

🌍 Impact and Influence

Prof. Ni’s work resonates far beyond the operating room. His integration of AI into anesthesiology research marks a forward-thinking approach to modern medicine. By exploring the cognitive effects of anesthesia, he contributes to improving surgical outcomes and patient safety, particularly in aging populations.

His leadership and mentorship roles at premier institutions like Peking University and the Cancer Hospital, CAMS, have helped nurture a generation of professionals equipped with both technical excellence and ethical insight.

Furthermore, his international collaboration with Harvard University has brought valuable cross-cultural research experience into Chinese clinical research settings, promoting a global standard in anesthesiology and perioperative medicine.

🌱 Legacy and Future Contributions

Looking ahead, Prof. Ni is poised to play a pivotal role in shaping the future of anesthesiology in cancer care. His continued emphasis on neuroprotection, chronic pain management, and artificial intelligence applications signals a progressive vision aligned with global health priorities.

As a Ph.D. supervisor and seasoned educator, his mentorship will continue to inspire emerging scholars. His innovations in clinical protocols and diagnostic tools will likely set new benchmarks in anesthetic safety and cancer patient recovery.

Prof. Cheng Ni stands as a bridge between tradition and innovation, combining deep clinical knowledge with research excellence to lead transformative change in anesthesiology and oncology care.

Publication Top Notes

Aged hippocampal single-cell atlas screening unveils disrupted neuroglial system in postoperative cognitive impairment

Author: Z., Suo, Zizheng, T., Xiao, Ting, Y., Qu, Yinyin, … H., Zheng, Hui, C., Ni, Cheng
Journal: Aging Cell
Year: 2025

Year: 2024

 

Wenjian Mao | Health Sciences | Best Researcher Award | 13235

Published on by Research Awards

Mr. Wenjian Mao | Health Sciences | Best Researcher Award

Mr. Wenjian Mao, Jinling Hospital, Nanjing University, China

Mr. Wenjian Mao is a postdoctoral researcher at the Department of Critical Care Medicine, Nanjing University, China. He holds a Medical Doctor degree from Nanjing Medical University and specializes in the diagnosis and treatment of acute pancreatitis, with a focus on clinical and experimental research. His academic contributions include multiple publications in prestigious journals, covering topics such as infected pancreatic necrosis, systemic anticoagulation, immune dysfunction, and kidney complications in acute pancreatitis. He is affiliated with Jinling Hospital, Nanjing University.

Profile

Orcid

Scopus

Early Academic Pursuits 🎓

Wenjian Mao embarked on his academic journey in medicine with a strong foundation at Guangzhou Medical University, where he earned his Bachelor of Medicine degree between 2011 and 2016. During this time, he developed a keen interest in medical sciences, particularly in the field of critical care and acute conditions. Building upon this foundation, he pursued a Master of Medicine at Southern Medical University from 2016 to 2019. His academic pursuits were characterized by a rigorous exploration of clinical medicine, setting the stage for his specialization in acute pancreatitis. His passion for advancing medical knowledge and patient care led him to enroll in the Medical Doctor program at Nanjing Medical University, where he further honed his expertise from 2019 to 2022. This progression through highly regarded medical institutions equipped him with a strong clinical and research background that would later define his professional contributions.

Professional Endeavors 🏥

Following his extensive education, Wenjian Mao took on the role of a postdoctoral researcher at Nanjing University’s Department of Critical Care Medicine. His professional experience is deeply rooted in the diagnosis and treatment of acute pancreatitis, a condition that presents significant challenges in critical care settings. His clinical practice at Jinling Hospital, affiliated with Nanjing University, has been instrumental in shaping his understanding of the disease’s complexities. He is actively engaged in both clinical and experimental research, striving to develop innovative approaches to the management and treatment of acute pancreatitis. His expertise encompasses patient assessment, therapeutic interventions, and longitudinal studies aimed at improving clinical outcomes. His work not only benefits individual patients but also contributes to the broader medical community’s understanding of acute pancreatitis management.

Contributions and Research Focus 📚

Wenjian Mao’s research is primarily focused on acute pancreatitis, with an emphasis on early detection, management, and patient outcomes. His scholarly contributions include a range of peer-reviewed publications that address critical aspects of pancreatitis treatment. His study on the prediction of infected pancreatic necrosis using the modified pancreatitis activity scoring system provides valuable insights into early intervention strategies. Additionally, his research on systemic anticoagulation in acute necrotizing pancreatitis patients has shed light on reducing hospital readmissions, improving patient recovery, and minimizing complications.

Other notable studies include his exploration of immune function in severe pancreatitis cases, where he was involved in a multicenter, double-blind, randomized controlled trial focusing on immune enhancement therapy. His work in identifying key biomarkers, such as mean absolute lymphocyte count as a predictor of infected pancreatic necrosis, further underscores his commitment to advancing diagnostic precision in the field. Moreover, his investigation into autoantibodies as independent risk factors for hypertriglyceridemia-induced pancreatitis recurrence highlights his innovative approach to understanding disease mechanisms. These contributions collectively enhance the medical community’s ability to diagnose, treat, and manage acute pancreatitis more effectively.

Accolades and Recognition 🏆

As a result of his groundbreaking work, Wenjian Mao has gained recognition in the medical research community. His studies have been published in reputable journals such as United European Gastroenterology Journal, Hepatobiliary Pancreatic Diseases International, Intensive Care Medicine, and the Journal of Clinical Lipidology. His findings have contributed to a growing body of literature that informs best practices in critical care and gastroenterology. Additionally, his collaborative efforts with other leading researchers have led to impactful studies on sepsis-related immune dysfunction and major adverse kidney events in pancreatitis patients. These accomplishments reflect his dedication to scientific excellence and his ongoing commitment to improving patient care.

Publication Top Notes

Triglyceride lowering in patients with different severities of hypertriglyceridaemia-associated acute pancreatitis: secondary analysis of a multicentre, prospective cohort study

Contributors: Xiang Luo; Xiaoling Li; Xiaoyan Lai; Wenjian Mao; Lu Ke; Lingyan Fu; Lin Gao; Yaolu Liu
Journal: BMJ Open Gastroenterology
Year: 2025

Immune-Enhancing Treatment among Acute Necrotizing Pancreatitis Patients with Metabolic Abnormalities: A Post Hoc Analysis of a Randomized Clinical Trial

Contributors: Xiaofei Huang; Wenjian Mao; Xingxing Hu; Fengxia Qin; Hui Zhao; Aiping Zhang; Xinyu Wang; Christian Stoppe; Dandan Zhou; Lu Ke et al.
Journal: Gut and Liver
Year: 2024

The Diagnosis and Treatment of Local Complications of Acute Necrotizing Pancreatitis in China: A National Survey

Contributors: Xiaowu Dong; Wenjian Mao; Lu Ke; Lin Gao; Jing Zhou; Bo Ye; Gang Li; Anthony Phillips; Zhihui Tong; John Windsor et al.
Journal: Gastroenterology Research and Practice
Year: 2021

RAGHURAM SHYAMSUNDER RAO | Health Specialist | Best Researcher Award

Published on by Research Awards

Dr. RAGHURAM SHYAMSUNDER RAO | Health Specialist | Best Researcher Award 

Assistant Director General at Central TB Division, Dept of Health, Ministry of Health & Family Welfare, Government of India, India

Dr. Raghuram Rao, the Assistant Director General of the Central TB Division in the Department of Health, Ministry of Health & Family Welfare, Government of India, is a seasoned Public Health Specialist with over 22 years of experience. His expertise spans managing communicable diseases such as TB, Leprosy, and HIV, and he has significantly contributed to public health program implementation, climate change, environmental health, and bio-medical waste management. In his current role, Dr. Rao leads epidemiology, surveillance, World Bank and Global Fund projects, Ni-kshay digital health innovations, policy and planning, and the integration of TB services into the general health system. His research interests include communicable diseases, public health program implementation, and environmental health. Dr. Rao has authored multiple research publications in peer-reviewed national and international journals. His research skills include leading epidemiological studies, implementing large-scale health programs, and utilizing digital health innovations for public health improvements. 📊🩺

Professional Profiles:

🎓 Education

Dr. Raghuram Rao has a robust educational background in public health, which has laid the foundation for his extensive work in the field. He holds a degree in Public Health, specializing in communicable diseases. His academic journey has equipped him with the knowledge and skills necessary to address complex public health challenges, particularly in the areas of TB, Leprosy, and HIV. Through continuous learning and professional development, Dr. Rao has remained at the forefront of public health advancements, contributing significantly to the implementation of health programs and research initiatives. 📘🔬🌐

Professional Experience

Dr. Raghuram Rao serves as the Assistant Director General at the Central TB Division, Dept of Health, Ministry of Health & Family Welfare, Government of India. With around 22 years of experience in public health, he has focused on communicable diseases such as TB, Leprosy, and HIV. His work extends to public health program implementation, Climate Change & Environmental Health, and Bio-medical Waste Management. In his current role, Dr. Rao leads epidemiology, surveillance, World Bank & Global Fund projects, Ni-kshay, digital health innovations, policy & planning, and the integration of TB services into the general health system. His dedication to public health is further demonstrated by his extensive research contributions in peer-reviewed national and international journals. 🩺📊🌍

Research Interest

Dr. Raghuram Rao’s research interests lie primarily in public health, with a focus on communicable diseases such as TB, Leprosy, and HIV. He is passionate about the implementation and impact of public health programs and policies. Dr. Rao’s work also extends to the fields of Climate Change & Environmental Health and Bio-medical Waste Management, where he explores the intersections between environmental factors and public health outcomes. His interest in epidemiology and surveillance is evident through his leadership in various projects under the World Bank and Global Fund. Additionally, Dr. Rao is keen on digital health innovations and their potential to revolutionize disease monitoring and health service delivery. His numerous publications in national and international peer-reviewed journals reflect his commitment to advancing knowledge in these critical areas of public health. 🌍📈💡

Award and Honors

Dr. Raghuram Rao has been recognized for his exceptional contributions to public health with numerous awards and honors. His dedication to combating communicable diseases such as TB, Leprosy, and HIV has earned him accolades from various national and international bodies. Dr. Rao’s innovative work in integrating digital health solutions into TB surveillance and management has been particularly celebrated. His leadership in World Bank and Global Fund projects has also garnered recognition, showcasing his ability to manage large-scale public health initiatives effectively. Additionally, Dr. Rao’s commitment to research and his extensive publication record in esteemed journals highlight his impact on the academic and professional community. His contributions to Climate Change & Environmental Health and Bio-medical Waste Management have further solidified his reputation as a versatile and influential public health specialist. 🌟🌍📜

Research Skills

Dr. Raghuram Rao possesses a comprehensive set of research skills honed over his 22 years in public health. He excels in epidemiology and surveillance, crucial for tracking and managing communicable diseases like TB, Leprosy, and HIV. Dr. Rao’s proficiency in policy and planning enables him to develop and implement effective health programs. His experience with World Bank and Global Fund projects demonstrates his capability in managing large-scale, international research initiatives. Dr. Rao is also skilled in integrating digital health innovations, such as Ni-kshay, to enhance TB service delivery and data management. His research has been widely published in peer-reviewed national and international journals, reflecting his ability to conduct rigorous scientific investigations. Additionally, Dr. Rao’s work in Climate Change & Environmental Health and Bio-medical Waste Management underscores his versatility and commitment to addressing diverse public health challenges. 🌐📊🩺

Publications

  1. Title: Need for operational simplicity and timely disbursal of benefits—a qualitative exploration of the implementation of a direct benefit transfer scheme for persons with tuberculosis in India
    • Authors: Mohan, M., Thangaraj, J.W.V., Pandey, S., Murhekar, M.V., Jeyashree, K.
    • Year: 2024
    • Journal: Infectious Diseases of Poverty
  2. Title: Direct benefit transfer for nutritional support of patients with TB in India—analysis of national TB program data of 3.7 million patients, 2018–2022
    • Authors: Jeyashree, K., Shanmugasundaram, P., Shanmugasundaram, D., Mattoo, S.K., Murhekar, M.V.
    • Year: 2024
    • Journal: BMC Public Health
  3. Title: Automatic Interpretation of Line Probe Assay Test for Tuberculosis
    • Authors: Agrawal, J., Kumar, M., Tiwari, A., Anand, S., Kumar, N.
    • Year: 2024
    • Journal: Proceedings of the AAAI Conference on Artificial Intelligence
  4. Title: Differentiated TB care: Tamil Nadu’s achievements, plans and implications for national TB programmes
    • Authors: Shewade, H.D., Frederick, A., Suma, K.V., Ramachandran, R., Murhekar, M.V.
    • Year: 2024
    • Journal: International Journal of Tuberculosis and Lung Disease
  5. Title: Sex-disaggregated patterns in tuberculosis treatment coverage and outcomes among a nationally representative sample of deaths in India: 2019–2022
    • Authors: Dandona, R., Kumar, G.A., Dora, S.S.P., Dandona, L., Rao, R.
    • Year: 2024
    • Journal: The Lancet Regional Health – Southeast Asia
  6. Title: Recurrence of pulmonary tuberculosis in India: Findings from the 2019-2021 nationwide community-based TB prevalence survey
    • Authors: Giridharan, P., Selvaraju, S., Rao, R., Gangakhedkar, R.R., Bhargava, B.
    • Year: 2023
    • Journal: PLoS ONE
  7. Title: Prevalence and factors associated with tuberculosis infection in India
    • Authors: Selvaraju, S., Velayutham, B., Rao, R., Panda, S., Bhargava, B.
    • Year: 2023
    • Journal: Journal of Infection and Public Health
  8. Title: Mortality estimates of central nervous system TB in India
    • Authors: Inbaraj, L.R., Rade, K., Selvaraju, S., Rao, R.
    • Year: 2023
    • Journal: International Journal of Tuberculosis and Lung Disease
  9. Title: Estimating the Burden of Tuberculosis in India: A Modelling Study
    • Authors: Mandal, S., Rao, R., Joshi, R.
    • Year: 2023
    • Journal: Indian Journal of Community Medicine
  10. Title: Patient adherence to tuberculosis treatment in the Indian subcontinent: Systematic review and meta-synthesis of qualitative research
    • Authors: Shringarpure, K., Gurumurthy, M., Sagili, K.D., Rao, R., Sachdeva, K.S.
    • Year: 2023
    • Journal: BMJ Open